Skip to main content
. 2024 Feb 1;17:533–543. doi: 10.2147/DMSO.S447127

Table 4.

General Clinical and Laboratory Parameter of All Subjects According to Serum Metrnl

Variable T1 T2 T3 P
Serum Metrnl (pg/mL) <233.65 233.65–346.24 ≥346.24
N 117 118 117
Percentage of MAFLD (%) 67.52 66.95 15.38 <0.001
Sex(M/F) 99/18 58/60 12/105 <0.001
#Age(years) 40(32−55) 46(33−58) 41(32−51) 0.103
#BMI(kg/m2) 26(24−27) 25(23−27) 23(21−24) <0.001
#WC(cm) 91(86−98) 89(84−95) 82(74−88) <0.001
*HC (cm) 101.76±6.36 100.10±5.81 98.71±7.27 0.003
#SBP (mmHg) 131(120−142) 128(117−139) 114(106−133) <0.001
#DBP (mmHg) 84(78−90) 83(78−88) 75(71−85) <0.001
#FBG(mmol/L) 5.23(4.87−5.89) 5.25(4.88−5.59) 4.92(4.58−5.23) <0.001
#TG(mmol/L) 1.44(1.04−1.95) 1.50(1.08−2.06) 1.01(0.71−1.42) <0.001
*TC (mmol/L) 5.11±0.87 5.09±1.02 4.68±0.83 <0.001
*LDL-C(mmol/L) 3.17±0.67 3.24±0.79 2.94±0.63 0.003
*HDL-C(mmol/L) 1.27±0.29 1.27±0.28 1.35±0.25 0.027
#UC(μmol/L) 363.20(307.35−423.50) 342.00(298.70−395.80) 299.40(260.75−347.45) <0.001
#ALT(U/L) 22.60(17.40−33.68) 17.90(14.57−26.95) 15.20(10.90−20.40) <0.001
#AST(U/L) 23.10(20.10−27.80) 22.40(19.70−26.70) 20.50(18.00−24.60) <0.001
#γ-GGT(U/L) 26.50(20.15−38.05) 22.60(19.05−31.30) 15.90 (13.30−22.65) <0.001
#Creatinine(μmol/L) 77(65−83) 67(59−80) 59.30(51.90−68.10) <0.001
#WBC(×109/L) 6.50(5.45−7.35) 6.30(5.50−7.30) 5.60(4.90−6.80) 0.005

Notes: *Data normally distributed are shown as mean ± SD. One-way ANOVA test was performed. #Data with skewed distribution are shown as median (25th−75th). Kruskal–Wallis test was performed.

Abbreviations: BMI, body mass index; WC, waist circumference; HC, hip circumference; SBP, systolic blood pressure; DBP, diastolic blood pressure; FBG, fasting blood glucose; TG, Triglyceride; TC, Total cholesterol; LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol; UA, uric acid; ALT, alanine aminotransferase; AST, aspartate aminotransferase; γ-GGT, γ-gamma glutamyl transferase; WBC, white blood cell.